Ingenuity Systems today announced that it had expanded the terms of its agreement with Sanofi-Aventis in the U.S. Ingenuity Pathways Analysis (IPA) is a web-delivered software application that enables researchers to model, analyze and understand the complex biological systems at the core of life science research. IPA is deployed in most major pharmaceutical companies, hundreds of biotechnology companies and academic institutions globally. It supports analysis of high-throughput analysis platforms; is used in virtually all areas of drug discovery and development——from target identification and validation— to biomarkers, predictive toxicology, and pharmacogenomics.